Antifungal agents.
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy; D002180:Candidiasis, Oral / Q000150:complications; D003963:Diaper Rash / Q000150:complications / Q000209:etiology; D004352:Drug Resistance, Microbial; D005260:Female; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009059:Mouth Diseases / Q000150:complications; D009761:Nystatin / Q000008:administration & dosage / Q000627:therapeutic use; D009824:Ointments; D010304:Paronychia / Q000188:drug therapy / Q000209:etiology; D011538:Pruritus Ani / Q000188:drug therapy; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy; D014005:Tinea / Q000175:diagnosis / Q000188:drug therapy / Q000635:transmission; D014008:Tinea Pedis / Q000175:diagnosis; D014010:Tinea Versicolor / Q000188:drug therapy
D000935:Antifungal Agents; D009824:Ointments; D009761:Nystatin; D006118:Griseofulvin; D000666:Amphotericin B